Sponsor:
Caliway Biopharmaceuticals Co., Ltd.
Code:
NCT07526974
Conditions
Subcutaneous Fat
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
CBL-514 Injection
0.9% Sodium Chloride
Brief summary:
Conditions
Subcutaneous Fat
Study ID
NCT07526974
Start date
Nov 9, 2026
Status verified date
Nov, 2026
Completion date
Oct, 2027
Anticipated
Primary completion date
Aug, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
320 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: CBL-514 injection
placebo comparator: Injectable 0.9% Sodium Chloride solution
Interventions
CBL-514 Injection
0.9% Sodium Chloride
Primary outcome measure
Central contacts
Locations
Investigational site 15
Recruiting
Miami, Florida, United States, 33126
Investigational site 16
Recruiting
Baton Rouge, Louisiana, United States, 70809
Sponsor
Caliway Biopharmaceuticals Co., Ltd.
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Caliway Biopharmaceuticals Co., Ltd. on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.